Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Defense + Military

    NAMRU-3 Deployed to Sudan: Yellow Fever Death Toll Hits 164

    By Global Biodefense StaffDecember 4, 2012
    Share
    Facebook LinkedIn Reddit Email

    Yellow Fever VirusThe World Health Organization (WHO) yesterday announced the acute viral hemorrhagic disease yellow fever has killed at least 164 people over the last three months in Sudan’s western region of Darfur. 

    The latest outbreak of the mosquito-borne virus has been concentrated in central Darfur. “Between 2 September and 29 November, the total number of suspected yellow fever cases has reached 677, including 164 deaths,” the WHO statement said. Nearly half the yellow fever cases were in people between the ages of 15 and 30, it said, and about a quarter were children aged five to 15.

    Healthcare is provided almost entirely by aid agencies in parts of Darfur, where armed conflict has been raging for a decade resulting in thousands of casualties and ongoing security challenges for vaccination campaigns. 

    A large-scale vaccination campaign is underway to counter the surge in yellow fever that began in September after a heavy rainy season created additional breeding sites for disease-carrying mosquitoes. According to the WHO, the campaign is over halfway towards the goal of reaching 3.6 million people in affected areas of Darfur.

    In addition to the epidemiology and surveillance assistance from the WHO and other organizations, the US Naval Medical Research Unit No. 3 (NAMRU-3) has deployed a team to Sudan to support laboratory analysis of collected samples as well as conduct training sessions at the National Public Health Laboratory, according to Examiner.com. 

    NAMRU-3 is based in Cairo, Egypt and conducts research and surveillance to support military personnel deployed to Africa, the Middle East, and Southwest Asia. The mission also includes regional public health capacity-building, evaluation of vaccines, therapeutic agents, diagnostic assays, and vector control measures. 

    The organization operates the largest DoD overseas laboratory, with a biosafety level 3 biocontainment space and field and hospital study sites located throughout Egypt. NAMRU-3 also serves as the regional influenza reference laboratory for the Eastern Mediterranean Regional Office (EMRO) of the World Health Organization (WHO) with close ties to the influenza laboratory at the U.S. Centers for Disease Control and Prevention (CDC). 

    Biosafety Mosquito-Borne Yellow Fever
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleNATO Seeks Input on CBRN Sensor Interface Standardization
    Next Article Naval Research Lab R&D Support

    Related Stories

    Needle-Free Vaccine Patch Against Zika Virus

    December 2, 2023

    NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox

    November 14, 2023

    COVID Moonshot Consortium Announces Crowd-Sourced Small Molecule Discovery

    November 11, 2023

    Call for Experts: Smallpox Medical Countermeasures

    October 28, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Dec 5
    10:45 am - 3:00 pm EST

    Meeting the Moment: Biodefense Policy, Procurement, and Public Health

    Dec 6
    Virtual Event Virtual Event
    6:00 am - 7:00 am EST

    AMR One Health Priority Research Agenda: Transmission

    Mar 12
    Virtual Event Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.